Joyce Sung: Presenting Our Work at The Fertility Society of Australia and New Zealand Annual Meeting 2026
Joyce Sung, Student Researcher at Monash University, shared on LinkedIn:
”It was a privilege to present our work at The Fertility Society of Australia and New Zealand Annual Meeting 2026 in Canberra.
Inositol has become a popular treatment option for PMOS and is the most widely marketed PMOS supplement. While inositol is included as a conditional recommendation in the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS, our review found that a large proportion of studies evaluating inositol do not meet our trustworthiness criteria.
These findings highlight the importance of assessing the trustworthiness of evidence underpinning clinical recommendations, which has direct implications for patient care.
Thank you to Ben Willem Mol, Daniel Rolnik, Nick Brown, Gideon Meyerowitz-Katz, and Madeline Flanagan for their support throughout this process.
Our work will be published soon. I look forward to sharing the full findings and continuing the conversation around data integrity and PMOS treatment.”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Aug 11, 2026, 16:14You Deserve Care That Treats You, Not a Statistic – Spring Fertility
-
Aug 11, 2026, 15:584 Voices, 15 Minutes, The Last Word of PCOS CON ’26 – PCOS Awareness Association
-
Aug 11, 2026, 15:47Esther Eleboh: Preventing OHSS in Women with PCOS/PMOS
-
Aug 11, 2026, 15:37Christina Walker: Can We Improve Fertility by Treating Metabolic Health Before Conception?
-
Aug 11, 2026, 15:30Devyanshi Dixit: Egg Freezing – What It Preserves and What It Doesn’t
-
Aug 11, 2026, 14:54Marie-Blanche Tchetgen: 7 Out of 10 Women Will Get Fibroids – Most Won’t See It Coming
-
Aug 11, 2026, 14:39Low AMH? The Number Is Not the Verdict – Fertility Plus
-
Aug 11, 2026, 14:25Aumatma Simmons: A Failed IVF Cycle Doesn’t Mean Pregnancy Is Impossible
-
Aug 11, 2026, 10:58Jennifer R. Berman։ Menopause Care Is Falling Short Because the Care Model Itself Is Fragmented…